Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Tammer BioLab Oy
OY
Active
Y-tunnus 0679027-7
Biokatu 10, 33520
Tampere
Manufacture of other chemical products n.e.c.
·
NACE 2059
Est. 1987 · 38 years old
20 employees
www.tammerbiolab.fi
Share
Finland
/
Companies
/
Manufacture of other chemical products n.e.c.
/
Tammer BioLab Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
275M
206M
138M
69M
0M
2021: 3M
3M
2021
2022: 3M (0% vs 2021)
3M
0%
2022
2023: 221M (+7267% vs 2022)
221M
+7267%
2023
2024: 2M (-99% vs 2023)
2M
-99%
2024
2025: 1M (-50% vs 2024)
1M
-50%
2025
EBITDA
EUR millions
90M
67M
45M
22M
0M
2021: 1M
1M
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: 72M (+7100% vs 2022)
72M
+7100%
2023
2024: 0M (-100% vs 2023)
0M
-100%
2024
2025: 0M
0M
2025
Income statement
EUR thousands
Item
2025
2024
2023
2022
2021
Revenue
1 144
1 737
220 990
2 656
2 965
Staff expenses
−817
−699
−75 807
−977
−1 454
EBITDA
26
467
72 291
1 128
502
Depreciation & amort.
−42
−52
−5 378
−49
−80
EBIT
−16
414
66 913
1 079
421
Net financials
−3
38
−51
−18
−4
Profit before tax
−19
452
61 839
1 061
417
Tax
−0
73
137
216
84
Net profit
−18
379
48 097
846
333
Balance sheet
EUR thousands
Item
2025
2024
2023
2022
2021
Total assets
677
827
222 032
1 827
1 136
Equity
476
495
187 200
1 512
724
Long-term debt
0
0
870
—
18
Short-term debt
201
332
33 962
315
393
Total debt
201
332
34 832
315
411
Financial ratios
5-year trend
EBITDA margin
2,3 %
This company
15,8 %
Market median
This company
Market median
85% below market
2021
2025
Equity ratio
70,4 %
This company
38,2 %
Market median
This company
Market median
84% above market
2021
2025
Return on equity
−3,9 %
This company
18,4 %
Market median
This company
Market median
121% below market
2021
2025
Net profit margin
−1,6 %
This company
8,1 %
Market median
This company
Market median
120% below market
2021
2025
Asset turnover
1,69×
This company
1,12×
Market median
This company
Market median
51% above market
2021
2025
Debt / equity
0,42×
This company
0,62×
Market median
This company
Market median
32% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
More on Tammer BioLab Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
